Information Center
Your Health. Your Family. Your Choice.
|
|
National Vaccine Information Center Your Health. Your Family. Your Choice. |
MedAlerts.org |
| Table |
 |   | |
| Age | Count | Percent |
| 6-17 Years | 1 | 0.49% |
| 18-29 Years | 11 | 5.42% |
| 30-39 Years | 16 | 7.88% |
| 40-49 Years | 23 | 11.33% |
| 50-59 Years | 16 | 7.88% |
| 60-64 Years | 12 | 5.91% |
| 65-79 Years | 26 | 12.81% |
| 80+ Years | 6 | 2.96% |
| Unknown | 92 | 45.32% |
| TOTAL | 203 | 100% |
| Case Details |
Administered by: Unknown Purchased by: ?
Life Threatening? No Write-up: Stevens Johnson Syndrome; rash was starting to peel; developed a rash all over her neck/ the rash has spread to face eyes, cheek; developed a rash all over her neck, "looks like its peeling and taut"; developed a rash all over her neck, "looks like its peeling and taut"; This is a spontaneous report from a contactable nurse (patient). A female patient of an unspecified age (Age: 48, Unit unknown) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 10Jan2021 at single dose for covid-19 immunization. Medical history included she had an allergic reaction to sulfa and developed Stevens Johnson syndrome from an unknown date and unknown if ongoing. The patient''s concomitant medications were not reported. The patient experienced Stevens Johnson Syndrome, developed a rash all over her neck/ the rash has spread to face eyes, cheek; "looks like its peeling and taut"; and the rash was starting to peel, all in Jan2021. The patient received 1st dose of vaccine on 10Jan2021, developed a rash all over her neck, "looks like its peeling and taut". She had an allergic reaction to sulfa and developed Stevens Johnson syndrome, this looks similar to that (Experience of Stevens Johnson Syndrome). The patient was asking if she did take the steroid dose pack from her dermatologist for the skin rash will it prohibit her from taking the second dose of the vaccine. She called yesterday and reported a rash after receiving the first dose of the COVID-19 vaccine. She stated that she went to her Dermatologist this morning because the rash has spread to face eyes, cheek and the rash was starting to peel. She stated that the dermatologist wanted to know if it was safe to treat her with a prednisone dose pack after receiving the vaccine. Her rash was worsening so she went to her dermatologist for treatment. She was asking if she should get the second dose. The outcome of events for developed a rash all over her neck/ the rash has spread to face eyes, cheek was not resolved, for other events was unknown. Information about lot/batch number has been requested.; Sender''s Comments: A possible causal association between administration of BNT162B2 and the onset of suspect Stevens Johnson Syndrome presented as skin reactions cannot be excluded, considering the plausible temporal relationship. Severe allergic reaction is the known risk for the vaccine. The underlying predisposing condition of an allergic reaction to sulfa developed Stevens Johnson syndrome may put the patient at high risk of the similar occurrence. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate | |||||||||||||||||
Administered by: Senior Living Purchased by: ?
Life Threatening? No Write-up: Presented from clinic with 3-4 days of extensive rash. There were multiple areas of skin sloughing on bilateral upper extremities and abdominal wall. | |||||||||||||||||
Administered by: Unknown Purchased by: ?
Life Threatening? No Write-up: Stevens-Johnson Syndrome; A spontaneous report was received from a health care provider regarding a 71-year-old female patient who received Moderna''s COVID-19 vaccine (mRNA-1273) and experienced Stevens Johnson Syndrome, which results in blisters and rashes all over the body. The patient''s medical history not included. No Concomitant medication was provided. On 02 Feb 2021, prior to the onset of the events, the patient received one of two planned doses of mRNA-1273 (Lot number: 025L20A) for prophylaxis of COVID-19 infection. On 03 Feb 2021, the day after the mRNA-1273 vaccine was given, the patient experienced Stevens Johnson Syndrome, causing rashes and blisters all over her body. Treatment information was not reported. Action taken with mRNA-1273 was not reported. The outcome of the events, Stevens Johnson Syndrome, causing rashes and blisters all over the patient''s body, was not reported.; Reporter''s Comments: Very limited information regarding this event has been provided at this time. Further information has been requested. | |||||||||||||||||
Administered by: Unknown Purchased by: ?
Life Threatening? No Write-up: Stevens Johnson syndrome; 1 blister on lip looks like outbreak of herpes; horrible outbreak of psoriasis; A spontaneous report was received from a healthcare professional concerning a 73-year-old patient who received Moderna''s COVID-19 vaccine (mRNA-1273) and experienced steven-johnson syndrome, oral herpes(blister on the lip which looks like an outbreak of herpes), psoriasis (bolus lesion on right arm, two bolus lesions on back, and legs). The patient''s medical history included bad psoriasis. Products known to have been used by the patient, within two weeks prior to the event, included secukinumab for psoriasis, which the patient took on 21 JAN 2021 as per the reporter. No other relevant concomitant medications was reported. On 28 Jan 2021, the patient received their first of two planned doses of mRNA-1273 for prophylaxis of COVID-19 infection. On 04-Feb-2021, it was reported that the patient had blister on the lip which looked like an outbreak of herpes. It was also reported that the patient had a bolus lesion on right arm, two bolus lesions on back, and legs, had a horrible outbreak of psoriasis. The physician mentioned that it appeared as Stevens Johnsons syndrome. Treatment included secukinumab for psoriasis. Action taken with mRNA-1273 was unknown. The outcome of the events, steven-johnson syndrome, oral herpes (blister on the lip which looks like an outbreak of herpes), psoriasis (bolus lesion on right arm, two bolus lesions on back, and legs), were unknown.; Reporter''s Comments: This case concerns a 73-year-old patient, who experienced Stevens-Johnson syndrome, oral herpes outbreak and outbreak of psoriasis. The patient''s medical history included bad psoriasis and patient is on cosentyx for psoriasis. Very limited information regarding this event/s has been provided at this time. Further information has been requested. | |||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: I visited my doctor. After he examined and questioned me about recent activities, he diagnosed me with a Stevens-Johnson response and said that my shot of the Moderna vaccine was the most likely cause of the incident. Much of my body was covered with red blisters and inflammation. It was uncomfortable and itched a lot. He prescribed a six-day course of methylprednisolone tablets for me, 21 - 4mg tablets over six days. That seemed to stop the reaction, but I still had badly inflamed hands and feet afterward. My doctor then prescribed prednisone, 1 - 10mg tablet per day. After another week, the inflammation was gone and I discontinued the prednisone. | |||||||||||||||||
Administered by: Unknown Purchased by: ?
Life Threatening? No Write-up: This spontaneous report was received from a physician referring to a 20-year-old female patient. The patient''s medical history, concomitant medications, drug allergies, or reactions were not reported. On an unspecified day in 2006, the patient was vaccinated with measles, mumps, and rubella (Wistar RA 27-3) virus vaccine, live (M-M-R II), one dosage form for prophylaxis (frequency, strength, route of administration, lot number, and expiry date were not reported). Other suspect therapies included sars-cov-2 vaccine (unspecified) (dose, frequency, strength, administration route, lot number, indication, and expiry date were not reported). On an unknown date, the patient experienced severe hives (urticaria), Stevens-Johnson syndrome, polyethylene glycol allergy (allergy to chemicals), and anaphylactic reaction. The outcome of an anaphylactic reaction, allergy to chemicals, and urticaria was unknown. The outcome of the Stevens-Johnson syndrome was reported as recovered/resolved. The reporter did not assess a causality relationship between the events and the suspect therapies. Upon internal review, the events of the Stevens-Johnson syndrome and anaphylactic reaction were determine to be medically significant. | |||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: PATIENT REFERS THAT TWO WEEKS AFTER RECEIVING HIS SECOND DOSE OF VACCINE STARTED WITH SKIN LESIONS. WAS DIAGNOSED WITH STEVEN JOHNSON | |||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: Stevens-Johnson Syndrome, angioedema; not responding to initial prednisone and antihistamine | |||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: Painful itchy rash, skin sloughing, Likely stephens Johnson syndrome | |||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: Stevens johnson syndrome/Small blisters first appeared in the nose and around the eyes a couple days; This is a spontaneous report from a contactable consumer (patient). A 71-year-old male patient received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in left arm on 28Jan2021 19:00 (Batch/Lot Number: el3247) as a single dose, and her second dose via an unspecified route of administration in left arm on 17Feb2021 11:30 (Batch/Lot Number: en7201) as a single dose for COVID-19 immunization. Medical history included allergies to sulfa and mycin drugs. Concomitant medications included Tamsulosin, atorvastatin, prasugrel, and acetylsalicylic acid (BABY ASPIRIN). The patient was not diagnosed with COVID-19 prior to vaccination. On 02Feb2021, the patient experienced Stevens Johnson Syndrome - small blisters first appeared in the nose and around the eyes a couple days after shot #1. It exploded with blisters all over face, neck and body a couple of days after the second shot. Patient had large blisters and open sores today and still getting new blisters 6 weeks after shot #2. Patient initially assumed that this was shingles in spite of the fact that he had the new shingles shot. He went to the doctor this morning and he diagnosed it as Stevens Johnson Syndrome. Biopsy was taken and sent to a lab. There was no other change in medication history, food, or exposure to potential allergens. Therapeutic measure included gabapentin to lessen pain. Events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Outcome of events was not recovered. The patient had not been tested for COVID-19 since the vaccination. | |||||||||||||||||
Link To This Search Result:
https://medalerts.org/vaersdb/findfield.php?TABLE=ON&GROUP1=AGE&EVENTS=ON&SYMPTOMS[]=Stevens-Johnson+syndrome+%2810042033%29&SYMPTOMS[]=Toxic+epidermal+necrolysis+%2810044223%29&VAX[]=COVID19&VAX[]=COVID19-2
Copyright ©
2024 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166